Literature DB >> 19679406

Simple carotid-sparing intensity-modulated radiotherapy technique and preliminary experience for T1-2 glottic cancer.

David I Rosenthal1, Clifton D Fuller, Jerry L Barker, Bryan Mason, John A Garcia, Jan S Lewin, F Christopher Holsinger, C Richard Stasney, Steven J Frank, David L Schwartz, William H Morrison, Adam S Garden, K Kian Ang.   

Abstract

PURPOSE: To investigate the dosimetry and feasibility of carotid-sparing intensity-modulated radiotherapy (IMRT) for early glottic cancer and to report preliminary clinical experience. METHODS AND MATERIALS: Digital Imaging and Communications in Medicine radiotherapy (DICOM-RT) datasets from 6 T1-2 conventionally treated glottic cancer patients were used to create both conventional IMRT plans. We developed a simplified IMRT planning algorithm with three fields and limited segments. Conventional and IMRT plans were compared using generalized equivalent uniform dose and dose-volume parameters for in-field carotid arteries, target volumes, and organs at risk. We have treated 11 patients with this simplified IMRT technique.
RESULTS: Intensity-modulated radiotherapy consistently reduced radiation dose to the carotid arteries (p < 0.05) while maintaining the clinical target volume coverage. With conventional planning, median carotid V35, V50, and V63 were 100%, 100%, and 69.0%, respectively. With IMRT planning these decreased to 2%, 0%, and 0%, respectively (p < 0.01). Radiation planning and treatment times were similar for conventional radiotherapy and IMRT. Treatment results have been excellent thus far.
CONCLUSIONS: Intensity-modulated radiotherapy significantly reduced unnecessary radiation dose to the carotid arteries compared with conventional lateral fields while maintaining clinical target volume coverage. Further experience and longer follow-up will be required to demonstrate outcomes for cancer control and carotid artery effects. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19679406      PMCID: PMC3307784          DOI: 10.1016/j.ijrobp.2009.04.061

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  54 in total

1.  The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning.

Authors:  Beong Choi; Joseph O Deasy
Journal:  Phys Med Biol       Date:  2002-10-21       Impact factor: 3.609

2.  Carotid intima-media thickness in patients with head and neck irradiation for the treatment of nasopharyngeal carcinoma.

Authors:  N M C So; W W M Lam; P Chook; K S Woo; K H Liu; S F Leung; K S Wong; C Metreweli
Journal:  Clin Radiol       Date:  2002-07       Impact factor: 2.350

3.  Neck irradiation: a risk factor for occlusive carotid artery disease.

Authors:  M Halak; S Fajer; H Ben-Meir; Z Loberman; B Weller; R Karmeli
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-04       Impact factor: 7.069

4.  Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years.

Authors:  Lucille D A Dorresteijn; Arnoud C Kappelle; Willem Boogerd; Willem J Klokman; Alfons J M Balm; Ronald B Keus; Flora E van Leeuwen; Harry Bartelink
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

5.  Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.

Authors:  Qiuwen Wu; Radhe Mohan; Andrzej Niemierko; Rupert Schmidt-Ullrich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

6.  Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy.

Authors:  John M Holland; Amir Arsanjani; Benny J Liem; S Christopher Hoffelt; James I Cohen; Kenneth R Stevens
Journal:  J Laryngol Otol       Date:  2002-03       Impact factor: 1.469

7.  Focused high-risk population screening for carotid arterial stenosis after radiation therapy for head and neck cancer.

Authors:  Scott R Steele; Matthew J Martin; Philip S Mullenix; James V Crawford; Daniel S Cuadrado; Charles A Andersen
Journal:  Am J Surg       Date:  2004-05       Impact factor: 2.565

8.  Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.

Authors:  Abderrahim Zouhair; David Azria; Philippe Coucke; Oscar Matzinger; Luc Bron; Raphael Moeckli; Huu-Phuoc Do; René-Olivier Mirimanoff; Mahmut Ozsahin
Journal:  Strahlenther Onkol       Date:  2004-02       Impact factor: 3.621

9.  Relative risk of stroke in head and neck carcinoma patients treated with external cervical irradiation.

Authors:  Jeffrey C Haynes; Mitchell Machtay; Randal S Weber; Gregory S Weinstein; Ara A Chalian; David I Rosenthal
Journal:  Laryngoscope       Date:  2002-10       Impact factor: 3.325

10.  Accelerated progression of carotid stenosis in patients with previous external neck irradiation.

Authors:  Stephen W K Cheng; Albert C W Ting; Pei Ho; Lisa L H Wu
Journal:  J Vasc Surg       Date:  2004-02       Impact factor: 4.268

View more
  21 in total

1.  Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.

Authors:  J-Y Lu; L-L Wu; J-Y Zhang; J Zheng; M L-M Cheung; C-C Ma; L-X Xie; B-T Huang
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

2.  Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation.

Authors:  Abdallah S R Mohamed; Blaine D Smith; Joshua B Smith; Parag Sevak; Jessica S Malek; Aasheesh Kanwar; Theodora Browne; G Brandon Gunn; Adam S Garden; Steven J Frank; William H Morrison; Jack Phan; Mark Zafereo; Heath Skinner; Stephen Y Lai; Katherine A Hutcheson; Jan S Lewin; Amy E Hessel; Apurva A Thekdi; Randal S Weber; Clifton D Fuller; David I Rosenthal
Journal:  Laryngoscope       Date:  2019-02-12       Impact factor: 3.325

3.  An investigation of intensity-modulated radiation therapy versus conventional two-dimensional and 3D-conformal radiation therapy for early stage larynx cancer.

Authors:  Daniel Gomez; Oren Cahlon; James Mechalakos; Nancy Lee
Journal:  Radiat Oncol       Date:  2010-08-26       Impact factor: 3.481

4.  Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.

Authors:  Zachary S Zumsteg; Nadeem Riaz; Sana Jaffery; Man Hu; Daphna Gelblum; Ying Zhou; Borys Mychalczak; Michael J Zelefsky; Suzanne Wolden; Shyam Rao; Nancy Y Lee
Journal:  Oral Oncol       Date:  2015-05-07       Impact factor: 5.337

5.  Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-14

6.  Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma.

Authors:  Karine A Al Feghali; Bassem Y Youssef; Abdallah S R Mohamed; Lara Hilal; Blaine D Smith; Ibrahim Abu-Gheida; Georges Farha; G Brandon Gunn; Jack Phan; Jan Lewin; Apurva Thekdi; William H Morrison; Adam S Garden; Clifton David Fuller; David I Rosenthal
Journal:  Head Neck       Date:  2020-06-02       Impact factor: 3.147

Review 7.  Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.

Authors:  D M Gujral; M Long; J W G Roe; K J Harrington; C M Nutting
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-11-01       Impact factor: 4.126

8.  Definitive radiotherapy for early stage glottic cancer by 6 MV photons.

Authors:  Chi-Chung Tong; Kwok-Hung Au; Roger Kai-Cheong Ngan; Foon-Yiu Cheung; Sin-Ming Chow; Yiu-Tung Fu; Joseph Siu-Kei Au; Stephen Chun-Key Law
Journal:  Head Neck Oncol       Date:  2012-05-18

9.  Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.

Authors:  Stefan Janssen; Christoph Glanzmann; Gerhard Huber; Gabriela Studer
Journal:  Radiat Oncol       Date:  2014-06-13       Impact factor: 3.481

10.  Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: A dosimetrical analysis.

Authors:  Eun Seok Kim; Seung-Gu Yeo
Journal:  Oncol Lett       Date:  2014-04-04       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.